Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
published in: Journal of the American College of Cardiology
date of publication: 2008-12-01
language: English
main subject: Chronic Thromboembolic Pulmonary Hypertension, placebo, thromboembolism
Cites articles
There is nothing here
Article - wd:Q46191143